Experiments in esophageal adenocarcinoma and Barrett’s esophagus cells revealed that cells treated with selective estrogen receptor ligands showed decreased cell growth and increased cell apoptosis23. The gene discussed is ESR1; the disease is esophageal adenocarcinoma.